Evergen

Evergen is a global Contract Development and Manufacturing Organization (CDMO) specializing in regenerative medicine, particularly in tissue engineering and biomaterial solutions. With a history of over 25 years, the company has contributed to more than 17 million life-enhancing implants worldwide. Formerly known as RTI Surgical, Evergen offers an integrated value chain that includes design, research and development, regulatory support, manufacturing, and supply chain management. The company provides a range of clinically proven allograft and xenograft biomaterials, which are utilized in various clinical segments such as plastic and reconstructive surgery, sports medicine, cardiac surgery, and neurosurgery. Evergen's services also encompass innovation in tissue engineering, regulatory expertise, and proprietary sterilization processes. With a dedicated team of over 850 employees and extensive manufacturing capabilities across the United States, Europe, and New Zealand, Evergen is committed to advancing patient outcomes through collaboration and continuous innovation.

• Employees 35
• Founded 1998
• Annual Revenue $9899000
• Total Funding $79800000